[Paper Review] Efficient augmentation and relaxation learning for individualized treatment rules using observational data

Ying‐Qi Zhao, Eric B. Laber+3 more|PubMed|Jan 3, 2019

Statistical Methods and InferenceMathematics29 references78 citations

TL;DR

The paper introduces EARL, a doubly robust, convex-relaxation approach for learning optimal individualized treatment rules from observational data, integrating both propensity score and outcome models. It provides theoretical risk/convergence guarantees and demonstrates improved finite-sample performance over existing methods.

ABSTRACT

Individualized treatment rules aim to identify if, when, which, and to whom treatment should be applied. A globally aging population, rising healthcare costs, and increased access to patient-level data have created an urgent need for high-quality estimators of individualized treatment rules that can be applied to observational data. A recent and promising line of research for estimating individualized treatment rules recasts the problem of estimating an optimal treatment rule as a weighted classification problem. We consider a class of estimators for optimal treatment rules that are analogous to convex large-margin classifiers. The proposed class applies to observational data and is doubly-robust in the sense that correct specification of either a propensity or outcome model leads to consistent estimation of the optimal individualized treatment rule. Using techniques from semiparametric efficiency theory, we derive rates of convergence for the proposed estimators and use these rates to characterize the bias-variance trade-off for estimating individualized treatment rules with classification-based methods. Simulation experiments informed by these results demonstrate that it is possible to construct new estimators within the proposed framework that significantly outperform existing ones. We illustrate the proposed methods using data from a labor training program and a study of inflammatory bowel syndrome.

Motivation & Objective

• Motivate the estimation of optimal individualized treatment rules (ITRs) from observational data under strong ignorability, consistency, and positivity assumptions.
• Develop a direct, scalable method that decouples the ITR class from outcome models to improve interpretability and robustness.
• Propose a convex-relaxation of augmented inverse probability weighted estimators to enable efficient computation and theoretical convergence guarantees.
• Establish double robustness: consistency of the rule when either the propensity score model or the outcome model is correctly specified.
• Provide theoretical risk bounds and rates of convergence for EARL under sample splitting and various convex surrogates.

Proposed method

• Define the ITR as a sign function d(x)=sgn{f(x)} with f in a measurable class to be optimized over a convex surrogate loss.
• Construct augmented value estimators using AIPWE to achieve double robustness with respect to the propensity score and outcome model.
• Formulate EARL as a convex-optimization problem minimizing a surrogate risk with a penalty, incorporating weights derived from estimated π and Q functions.
• Introduce sample splitting to separate nuisance function estimation (π, Q) from the risk minimization step, enabling weaker entropy conditions.
• Show that maximizing the AIPWE-based criterion is equivalent to minimizing a weighted 0-1 loss, which is approximated by convex surrogates (hinge, logistic, exponential, squared hinge).
• Provide theoretical results linking surrogate risk to value function risk and deriving convergence rates depending on the surrogate, the nuisance-function rates, and the approximation space.

Experimental results

Research questions

• RQ1 Can we estimate an optimal ITR from observational data in a doubly robust, computationally efficient way that remains interpretable within a pre-specified rule class?
• RQ2 How do different convex surrogate losses and nuisance-function estimation rates affect the convergence and accuracy of the estimated ITR within EARL?
• RQ3 Does sample splitting relax entropy conditions and provide robust theoretical guarantees for the EARL estimator?
• RQ4 In what scenarios do EARL estimators outperform existing methods like OWL or IPWE-based approaches in finite samples?
• RQ5 What are the theoretical risk bounds connecting surrogate risk to the value function risk under EARL?

Key findings

• EARL provides a doubly robust framework: the estimated ITR is consistent if either the propensity model or the Q-function model is correctly specified.
• Maximizing the concave relaxation of the AIPWE reduces to minimizing a weighted surrogate loss, enabling efficient optimization in high dimensions.
• Convergence rate results show how the choice of convex surrogate, nuisance-function rates, and the approximation space affect performance.
• Sample splitting removes dependence between nuisance estimation and the empirical risk minimization, relaxing entropy requirements and improving theoretical guarantees.
• EARL includes OWL as a special case and can achieve faster finite-sample performance than IPWE-based methods due to the multiplicative error structure between π and Q estimates.
• Simulation studies, informed by theory, demonstrate substantial finite-sample improvements over existing methods; real-data illustrations include a labor training program and an inflammatory bowel syndrome study.